What do we know about adenovirus in renal transplantation?

Nephrol Dial Transplant. 2013 Aug;28(8):2003-10. doi: 10.1093/ndt/gft036. Epub 2013 Mar 13.


Adenoviruses are common pathogens that have the potential to cause opportunistic infections with significant morbidity and mortality in immunocompromised hosts. The significance of adenoviral infection and disease is incompletely known in the setting of kidney transplantation. Reported adenovirus infections in renal transplant recipients have typically manifested as hemorrhagic cystitis and tubulointerstitial nephritis, less severe diseases than often seen in other solid organ transplant recipients (i.e. pneumonia, hepatitis and enteritis). The prevalent adenovirus subgroups associated with cystitis and nephritis are B1 and B2 with the serotypes 7, 11, 34, 35. However, disseminated or severe adenovirus infections, including fatal cases, have been described in renal transplant recipients. There is uncertainty regarding monitoring of and treatment of this virus. Although not supported by randomized clinical trials, cidofovir is used for the treatment of adenovirus disease not responding to reduction of immunosuppression.

Keywords: adenovirus; disease; infection; kidney transplantation; renal transplantation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenoviridae / pathogenicity*
  • Adenoviridae Infections / diagnosis*
  • Adenoviridae Infections / drug therapy
  • Adenoviridae Infections / etiology
  • Antiviral Agents / therapeutic use
  • Humans
  • Kidney Diseases / complications*
  • Kidney Diseases / therapy
  • Kidney Diseases / virology
  • Kidney Transplantation / adverse effects*


  • Antiviral Agents